-
Golgi-Tracker Green for Live-Cell Golgi Imaging
2026-09-18
Golgi-Tracker Green enables selective, photostable visualization of Golgi membranes in living cells while supporting lipid transport and sphingolipid studies. This practical guide combines an executable labeling workflow with assay controls, troubleshooting, and a cautious translation of recent cancer-Golgi research.
-
Trypsin-Responsive Nanomedicine for Acute Pancreatitis
2026-09-18
This ACS Nano study introduces a mesoporous organosilica system that combines pancreatic acinar-cell targeting with trypsin-triggered delivery of the intracellular calcium chelator BAPTA-AM. Its results support a mechanism-oriented treatment strategy that intervenes in calcium overload, oxidative injury, inflammation, and necrotic signaling rather than addressing only downstream symptoms.
-
NVP-BGJ398 phosphate: Signal to Phenotype
2026-09-17
NVP-BGJ398 phosphate is a potent FGFR1–3 inhibitor for connecting receptor signaling with measurable cancer and cartilage phenotypes. This evidence-led guide shows how to design, validate, and interpret experiments without confusing pathway suppression with disease-specific efficacy.
-
Exogenous NADH Potentiates Antibiotics Against E. tarda
2026-09-17
A 2024 Virulence study shows that exogenous NADH can reprogram Edwardsiella tarda metabolism, increase ATP availability, and strengthen the bactericidal activity of neomycin and other antibiotic classes. The work supports metabolic intervention as an antibiotic-adjuvant strategy while identifying ATP-linked energy metabolism as a practical mechanistic focus for resistance research.
-
Circular RNA Vaccines: Design, Evidence, and Limits
2026-09-16
The review by Niu, Wu, and Lian explains how covalently closed circular RNA can address several limitations of linear mRNA vaccines, particularly instability and susceptibility to degradation. It synthesizes evidence on circRNA design, synthesis, purification, delivery, and early applications in infectious disease and cancer, while emphasizing that optimization and clinical validation remain incomplete.
-
Intestinal TM6SF2 and the Gut–Liver Axis in MASH
2026-09-15
The reference study shows that intestinal, rather than solely hepatic, TM6SF2 deficiency can initiate MASH through altered fatty-acid handling, barrier failure, microbial dysbiosis and gut-derived lysophosphatidic acid. Its genetic, germ-free transplantation, co-housing and pharmacological experiments establish a mechanistic gut–liver axis and identify LPA-receptor signaling as a tractable intervention point.
-
Improving In Vitro Drug Response Evaluation in Cancer
2026-09-15
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent drug-response dimensions. This framework supports more interpretable assay design by encouraging researchers to measure response magnitude, mechanism, and timing separately rather than relying on a single viability endpoint.
-
Stable-Isotope UHPLC–MS/MS for Methylated Nucleosides
2026-09-14
Zhang, Zhang, and Wang developed a stable isotope-diluted UHPLC–ESI-MS/MS workflow for simultaneous measurement of 12 purine ribonucleosides, including 10 methylated species. Ammonium bicarbonate-enhanced ionization, chromatographic resolution of isomers, and methanol–SPE cleanup improved sensitivity for intracellular analysis and strengthened the analytical basis for RNA modification research and nucleoside biomarker discovery.
-
MACC1–HNRNPH1 Control of IRAK1 Splicing in LUAD
2026-09-14
The reference study identifies a direct connection between the oncogenic factor MACC1, the splicing regulator HNRNPH1, and IRAK1 isoform selection in lung adenocarcinoma. Its findings suggest that MACC1 promotes tumor-associated phenotypes by preserving the long IRAK1 isoform, providing a mechanistic framework for studying cancer-relevant alternative splicing.
-
Mitochondrial Pore Opening in Translational Research
2026-09-13
Mitochondrial permeability transition pore opening can connect mitochondrial dysfunction with cell-death decisions. This thought-leadership guide combines mechanistic interpretation, evidence from idiopathic carpal tunnel syndrome research, assay controls, and strategic guidance for using Calcein AM fluorescence in translational studies.
-
CARMIL MB Domain Regulates Actin Capping Protein
2026-09-12
A January 2026 preprint identifies the CARMIL membrane-binding domain as an active regulator rather than a passive membrane anchor. Its findings suggest that membrane attachment, CP recruitment, membrane release, uncapping, and Arp2/3-dependent actin assembly are coordinated through a dynamic MB–CP interaction.
-
Spermine Workflows for Ion Channel Research
2026-09-12
Spermine provides a biologically relevant way to probe inward rectifier potassium channel modulation, from voltage-controlled electrophysiology to carefully bounded membrane-fusion experiments. This workflow emphasizes concentration planning, solution handling, orthogonal controls, and clear separation between established channel biology and emerging CLCC1 research.
-
Thrombin B Chain Fragment in Fibrin Assays
2026-09-11
Use a sequence-defined human thrombin B chain fragment to separate peptide-associated effects from catalytic thrombin biology in fibrin, endothelial, platelet, and vascular workflows. This guide translates fibrin-matrix angiogenesis findings into practical assay controls, preparation parameters, and troubleshooting decisions.
-
(S)-(+)-Dimethindene maleate: Lab Guide
2026-09-11
This guide explains how to use (S)-(+)-Dimethindene maleate as a research tool for separating M2 muscarinic and H1 histamine receptor contributions in receptor and physiology assays. It is intended for controlled in vitro or ex vivo workflows, not for diagnostic, therapeutic, or medical use, and no directly matched paper evidence for SKU B6734 is assumed.
-
Sisomicin Workflows for Antibacterial Research
2026-09-10
Build more reliable Sisomicin assays by connecting 30S ribosome activity with paired extracellular, intracellular, and exposure-response measurements. This practical guide distinguishes product-backed conditions from hypothesis-generating workflow adaptations for Gram-negative and Gram-positive infection research.